SCHEMBL6544801

SCHEMBL6544801

Cn1c(CO)nc2c(Oc3ccccc3C#N)cccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.40
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 4/20 0.38
MAPK1 P28482 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
TSHR P16473 2/20 0.38
RECQL P46063 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PKM P14618 1/20 0.38
ALOX12 P18054 1/20 0.38
HIF1A Q16665 1/20 0.38
RAB9A P51151 1/20 0.36
RHEB Q15382 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1161593 0.71 GRM2 (0.39) PPARGLMNANPSR1SMN1; SMN2KDM4E
SCHEMBL22894792 0.68 PPARG (0.40) PPARGPOLBGAALMNASMN1; SMN2
SCHEMBL7054403 0.68 GAA (0.64) POLBGAAMAPK1SMN1; SMN2TSHR
SCHEMBL8431375 0.66 GAA (0.62) POLBGAAMAPK1SMN1; SMN2TSHR
SCHEMBL7364275 0.66 HPGDS (0.43) MAPTRAB9A
SCHEMBL15780474 0.65 MAPT (0.37) PPARGPOLBLMNANPSR1SMN1; SMN2
SCHEMBL104281 0.64 HDAC6 (0.61) POLBGAALMNASMN1; SMN2KDM4E
SCHEMBL14685303 0.64 RAB9A (0.57) LMNAMAPK1SMN1; SMN2MAPTMEN1
SCHEMBL1161432 0.64 RAB9A (0.50) LMNAMAPK1KDM4EMEN1KMT2A
SCHEMBL3158064 0.63 POLB (0.63) POLBGAAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP disclosed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US disclosed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP disclosed